Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
ID: 352976Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352976

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-24-014.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Mar 14, 2024 12:00 AM
  4. 4
    Due Jul 8, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)". This grant aims to support collaborative and translational research projects focused on chemically complex botanical and other natural products relevant to dietary supplements. The goal is to conduct highly informative clinical trials to measure the effects of these products on quantitative, objective measures of human resilience.

The grant seeks to foster dynamic and synergistic interactions among experts from various disciplines to ensure rigor in all aspects of the research. The projects will be carried out by multi-PD/PI teams working on integrated specific aims. The research outcomes will include optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of critical knowledge and methods for interpreting such a trial.

The grant also emphasizes the importance of enhancing workforce and institutional capacity to conduct rigorous, transdisciplinary research on chemically complex natural products. The ultimate aim is to provide a strong foundation for a future highly informative clinical efficacy trial on the effects of resilience using a chemically complex natural product.

This grant opportunity is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of the program include RFA-AT-24-008, which focuses on leveraging data at scale to understand natural product impacts on whole person health (R01), and RFA-AT-24-007, which is a limited competition for a research resource on natural product nuclear magnetic resonance data (R24).

The deadline for applications is July 8, 2024. The maximum award ceiling is $1,500,000. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic (non-U.S.) entities (foreign organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. territories or possessions.

For more information and to apply, please visit the following link: Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-OD-24-014-Full-Announcement.html
4/10/2024
Similar Opportunities
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)". This grant aims to support investigator-initiated, early phase, clinical trials of natural products, including botanicals, probiotics, and dietary supplements. The trials should have a strong scientific premise and provide valuable information for further clinical testing and development of the natural product. The grant provides up to three years of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural product's effect on a specified target measure. If milestones are achieved, additional support may be awarded to replicate the impact of the natural product on target engagement and assess its association with clinical outcomes. The grant does not require cost sharing or matching. The deadline for applications is November 13, 2026. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-124.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-124.html).
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)". This opportunity falls under the category of Health and is a Cooperative Agreement. The grant is open to eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply. The grant aims to support a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, administrative support, data management, and biostatistical support for the proposed clinical trial. The clinical trial must be relevant to the research mission of the NCCIH (National Center for Complementary and Integrative Health) and considered a high priority by the Center. Applicants are encouraged to consult the NCCIH website for additional information about the mission, strategic vision, and research priorities of the Center. It is strongly recommended that applicants contact the appropriate Scientific/Research contact for the area of science they are planning to develop an application for prior to submitting to this grant opportunity. The application must include a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Failure to include a PEDP will result in the application being considered incomplete and withdrawn. For more information and to access the full opportunity announcement, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-125.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-125.html). Any further inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is seeking applications for a Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products. This opportunity falls under the category of Health and is a Cooperative Agreement. The purpose of this funding is to support investigator-initiated, multi-site clinical trials to study the effects of natural products in NCCIH designated areas of high research priority. Natural products include botanicals, probiotics, and products marketed as dietary supplements. The Clinical Coordinating Center will be responsible for developing and implementing the proposed multi-site clinical trial. This includes project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. The funding mechanism for this opportunity is a two-phase, milestone-driven, cooperative agreement (UG3/UH3). Applicants are also required to submit a Data Coordinating Center application for data analysis and management. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for submission is July 14, 2026. For more information and to apply, please visit the NIH website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-123.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-123.html).
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)". This grant aims to support investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs, commonly known as mind and body interventions. The purpose of this grant is to gather new scientific information necessary for the planning and implementation of subsequent clinical trials within NCCIH's mission. Under this grant, applicants are expected to propose a multisite feasibility clinical trial that will provide valuable insights for the design and planning of future clinical efficacy or effectiveness studies. The collected data should address gaps in scientific knowledge, such as assessing the delivery of interventions across multiple sites, demonstrating feasibility of participant recruitment and retention, and refining protocolized multimodal interventions. The goal is to develop a competitive, fully powered multisite clinical trial that can have a significant impact on public health. The grant does not require cost sharing or matching funds. It falls under the category of Health and is a discretionary funding opportunity. The closing date for applications is November 17, 2026. The maximum award ceiling is $350,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). However, non-domestic (non-U.S.) entities and components are not eligible to apply. For more information and to apply for this grant, please visit the following link: [NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-083.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)". This grant is part of the Health category and falls under the Cooperative Agreement funding instrument type. The grant does not require cost sharing or matching. The purpose of this grant is to support investigator-initiated multi-site clinical trials that study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs, as well as multicomponent interventions that include physical, psychological, and/or nutritional approaches in NCCIH-designated areas of high research priority. The Clinical Coordinating Center (CCC) is responsible for developing and implementing the proposed fully powered multi-site clinical trial (Phase III and beyond). The CCC application should include a scientific rationale and a comprehensive scientific and operational plan for the clinical trial, as well as plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Applicants are also required to submit a Data Coordinating Center (DCC) application proposing a data analysis and data management plan for the clinical project. Both the CCC application and the corresponding DCC application need to be submitted simultaneously for consideration by NCCIH. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply. The deadline for submission of applications is July 13, 2026. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-090.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-090.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.